Cargando…
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer
Targeting the activation function-1 (AF-1) domain located in the N-terminus of the androgen receptor (AR) is an attractive therapeutic alternative to the current approaches to inhibit AR action in prostate cancer (PCa). Here we show that the AR AF-1 is bound by the cochaperone Bag-1L. Mutations in t...
Autores principales: | Cato, Laura, Neeb, Antje, Sharp, Adam, Buzón, Victor, Ficarro, Scott B, Yang, Linxiao, Muhle-Goll, Claudia, Kuznik, Nane C, Riisnaes, Ruth, Nava Rodrigues, Daniel, Armant, Olivier, Gourain, Victor, Adelmant, Guillaume, Ntim, Emmanuel A, Westerling, Thomas, Dolling, David, Rescigno, Pasquale, Figueiredo, Ines, Fauser, Friedrich, Wu, Jennifer, Rottenberg, Jaice T, Shatkina, Liubov, Ester, Claudia, Luy, Burkhard, Puchta, Holger, Troppmair, Jakob, Jung, Nicole, Bräse, Stefan, Strähle, Uwe, Marto, Jarrod A, Nienhaus, Gerd Ulrich, Al-Lazikani, Bissan, Salvatella, Xavier, de Bono, Johann S, Cato, Andrew CB, Brown, Myles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629025/ https://www.ncbi.nlm.nih.gov/pubmed/28826504 http://dx.doi.org/10.7554/eLife.27159 |
Ejemplares similares
-
A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway
por: Kuznik, Nane C., et al.
Publicado: (2022) -
Whole transcriptome data analysis of zebrafish mutants affecting muscle development
por: Armant, Olivier, et al.
Publicado: (2016) -
Loss of function of myosin chaperones triggers Hsf1-mediated transcriptional response in skeletal muscle cells
por: Etard, Christelle, et al.
Publicado: (2015) -
Multi-Dimensional Transcriptome Analysis Reveals Modulation of Cholesterol Metabolism as Highly Integrated Response to Brain Injury
por: Gourain, Victor, et al.
Publicado: (2021) -
Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy
por: Pan, Mengwu, et al.
Publicado: (2023)